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MYTH 1
The growing number of older people has been the 
primary factor driving the rise in America’s health
care costs.
Fact: Population aging is not the principal determi-
nant of rising health care costs.
Health care costs in the United States have risen
sharply in the past several decades not only in
actual dollars but also as a proportion of the gross
national product. While the proportion of
Americans over age 65 is rising and older adults
consume more health care than younger adults,
the contribution of aging to rising costs is actually
quite limited.
Research conducted by the Center for Studying
Health System Change reveals that in 2001,
while the annual percentage increase in per capita 
non-Medicare personal health expenditures was 
8.1 percent, less than 10 percent of this (only 
0.73 percentage point) was attributable to popula-
tion aging.1 Medical care price inflation, greater
resource intensity of treatments, including the
availability of new technology, and overall popula-
tion growth have been responsible for the major-
ity of the rise in health care costs.
In a four-part series of articles discussing rising
health care costs published in the Annals of
Internal Medicine, Thomas Bodenheimer, M.D.,
points out that research consistently shows that
the aging population explains only 6 to 7 percent
of health expenditure growth, and no significant
relationship is found between the percentage of
older persons in a nation’s population and
national health spending.2
Using national household surveys and Centers for
Medicare & Medicaid Services National Health
Accounts data in an analysis presented in Health
Affairs in 2004, Ellen Meara and colleagues con-
clude that population aging accounts for only a
small part of medical spending growth since
1970: only 0.2 percentage points of the annual
rate of 4.3 percent.3
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Even after the baby boom generation begins to
reach 65, around the year 2010, the increases in
the fraction of the U.S. population age 65 and over
will be only a minor determinant of the annual
growth in aggregate health care use and spending.
This is because the U.S. population age 65 and
over will rise ever so gradually, by fewer than ten
percentage points between now and 2030.4
Thus, to assume that population aging has been
the major source of rising health care costs is a
mistake and detracts from the more serious deter-
minants of rising costs. As Reinhardt puts it in a
study using Medical Expenditure Panel Surveys
to evaluate the role of the aging population on
health care costs:
Key factors responsible for the growth in
health care spending include rising per capita
incomes, the availability of promising but
costly new medical technology, workforce
shortages that can drive up the unit cost of
health care, and the asymmetric distribution
of market power in health care that gives the
supply side of the sector considerable sway
over the demand side. These other factors
will be the dominant drivers of health spend-
ing in the future as well. Blaming Medicare’s
future economic pressures mainly on demo-
graphic factors beyond policymakers’ control
is an evasion of more important challenges.4
MYTH 2
As the population ages, health care costs for older
Americans will necessarily overwhelm and bankrupt
the nation.
Fact: Population aging need not impose a crush-
ing economic burden, especially if we start now to
conduct the necessary research and develop poli-
cies on health care at the end of life.
There is good evidence that the health status of
older Americans is improving and that longer
healthy life may not cause a significant increase 
in health care spending.1 A recent analysis using
Medicare data showed that for persons who reach
the age of 70 in good health and who have several
remaining years of life, the cumulative health care
expenditures until death are similar to those for
persons in poor health at the age of 70. Health
promotion efforts in the areas of smoking cessa-
tion, diet, and exercise in the younger population
that have payoffs in better health and longer life
for older persons will keep health care spending
from increasing among this older cohort.
Using data from the National Long-Term Care
Survey, Manton and colleagues have shown sig-
nificant reductions over the past two decades in
the prevalence of chronic disability among older
adults. While the number of older Americans has
grown from 26.9 million in 1982 to 35.5 million
in 1999, the number of chronically disabled has
actually decreased from 7.1 million to 7.0 million.
The prevalence of chronic disability declined 
to 6.5 percent.2
         
Furthermore, there is reason to believe that the pro-
tocol used in this survey overestimated the degree of
disability and thus has misclassified survey respon-
dents. In an analysis published in the Archives of
Internal Medicine in 2005, researchers found the
number of chronically disabled older Americans to be
about 2.0 million fewer than the 7.0 million pub-
lished for 1999, suggesting that the burden of chronic
disability has been substantially overestimated.4
In its report entitled 65+ in the United States: 2005,
the United States Census Bureau describes an
increasingly healthier, wealthier, and better-educated
cohort of older adults reaching retirement age. The
report cites an overall improved health expectancy,
with more years free of disability.5
Only part of the added life expectancy is spent in
good health, and thus it is not surprising that the rate
of increase in expenditure for long-term care rises
with age at death.6 The opposite trend is true of
acute-care expenditure for which the rate of increase
declines with age at time of death. Future research on
compression of morbidity (augmenting the disability-
free years among the older population) could stem the
increase in long-term care expenditure. Meanwhile, it
is not aging as such that creates health care expendi-
ture but services needed when death is imminent.
MYTH 3
Putting limits on health care for the very old at 
the end of life would save Medicare significant
amounts of money.
Fact: The proportion of Medicare spending attribut-
able to beneficiaries in the last year of life has
remained stable over the past two decades.
Rational political decisions about end-of-life care,
integrating respect for human life with quantitative
aspects, would prevent this from being an issue. 
3
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As life expectancy among older persons improves,
so does their health. Those in good health appear to
have a longer life expectancy than those in poor
health but have similar cumulative health care
expenditures until death.1 For example, in 1998 a
person with no functional limitation at age 70 had a
life expectancy of 14.3 years and expected cumula-
tive health care expenditures of about $136,000; a
person with a limitation in at least one activity of
daily living had a life expectancy of 11.6 years and
expected cumulative health care expenditures of
about $145,000 (in 1998 dollars). There are greater
costs when older people are institutionalized. Those
who were institutionalized at the age of 70 had
cumulative health care expenditures that were much
higher than those who were not institutionalized.
However, over three-fifths of the cost of institu-
tional care is paid by individuals and state and local
government, rather than by Medicare (see Figure 5).
Spillman and Lubitz analyzed the effect of
longevity on spending for acute and long-term
care.2 They examined data from Medicare, the
National Mortality Followback Survey, and the
National Medical Expenditure Survey to estimate
total national expenditures for health care according
to the age at death. They found that people who die
at an older age do incur higher expenditures overall
but actually cost Medicare less. Acute care expendi-
tures, principally for hospital care and physicians’
services, increase at a reduced rate as the age at death
increases. The increases in cost are primarily in
long-term care, which is significantly paid for by
state/local funds and out-of-pocket funds.3 Overall,
the proportion of Medicare spending attributable to
beneficiaries in the last year of life has remained sta-
ble at approximately 25 percent over the past two
decades and is not disproportionately responsible for
the Medicare spending increase.4
Yang et al. concur that aging accounts principally
for higher long-term care costs, but that increased
time to death is the main reason for higher inpa-
tient care expenditures.5 Both of these expenditures
Sources of Nursing Home Care Payments, 1960–1995 (in percent). (Latest data available.)
Figure 5
Calendar Out-of-Pocket Private Health Other Federal State and Total Expenditures
Year Payments Insurance Private Spending Local Spending (in millions)
1960 77.9 0.0 6.4 7.9 7.8 848
1965 60.1 0.1 5.7 15.0 19.0 1,471
1970 53.5 0.4 4.9 24.8 16.4 4,217
1975 42.6 0.7 4.8 30.5 21.3 8,668
1980 41.8 1.2 3.0 31.8 22.2 17,649
1985 44.4 2.7 1.8 29.8 21.2 30,679
1990 43.6 3.7 1.8 30.8 20.0 50,928
1991 40.9 3.6 1.8 32.2 21.5 57,164
1992 39.1 3.4 1.9 34.5 21.2 62,301
1993 37.4 3.3 1.9 36.8 20.7 67,029
1994 37.1 3.3 1.9 37.1 20.6 72,446
1995 36.7 3.3 1.9 37.6 20.5 77,877
SOURCE: Committee on Ways and Means, U.S. House of Representatives. 1997. Medicare and health care chartbook. Feb 27, 1997. U.S. Government Printing
Office, Washington, DC. http://www.gpo.gov/congress/house/ways-and-means/sec1.pdf
            
will likely increase due to the increase in the
absolute number of older people, as well as increas-
ing longevity. But it is important to remember that
population aging is not the principal determinant
of rising health care costs (refer to Myth 1). The
RAND Future Elderly Model points out that new
technologies add to spending because the costs of
the new technologies, and the health care costs
during the added years of life they bring, outweigh
reductions in annual spending from better health.6
For the above reasons, even if physicians and hospi-
tals could predict which patients were near death,
limiting acute care would not save the amount of
money that many assume. The larger problem is
that Medicare as a reimbursement structure has not
built in a cost-reduction incentive. Some programs
within Medicare, such as the hospice benefit, may
provide some cost control because of the capitated
payment structure.7 However, there are no recent or
definitive studies examining this issue. Existing
data, mainly from the 1980s, suggest that hospice
and advance directives can save between 25 and 40
percent of health care costs during the last month
of life, with savings decreasing to 10 to 17 percent
over the last six months of life and decreasing fur-
ther to 0 percent to 10 percent over the last 12
months of life.8 These savings are less than most
people anticipate. Nevertheless, they do indicate
that hospice and advance directives should be
encouraged because they do not cost more and they
provide a means for patients to exercise their
autonomy over end-of-life decisions.
More recently, the Dartmouth Atlas Project 2006,
which reports on the care of patients (Medicare
enrollees) with severe chronic illness during the last
two years of life, has provided important insights.9
This project found that there are tremendous
regional and state variations in the management of
patients with serious chronic illnesses, including
mean number of doctor visits in the last six
months of life, percentage of deaths occurring in
the intensive care unit setting, percentage of dece-
dents enrolled in hospice, and amount of Medicare
spending in the last six months of life. They found
that regional differences in Medicare spending are
largely explained by the inpatient-based and spe-
cialist-oriented pattern of practice (as opposed to
primary care) observed in high-spending regions.
More resource use did not result in better out-
comes or satisfaction with care, and, indeed,
regions with greater care intensity had increased
mortality rates.10,11
In summary, acute care for the very old at the end
of life does not appear to be a major item in the
nation’s health care bill nor a potential area for
large savings. As Scitovsky states, “Curbing the rise
in medical care costs will require basic changes in
the physician-patient relationship and in our atti-
tude to death.”12 We as a nation need to rethink,
retool, and reprioritize the way we deliver care,
especially in the face of increasing numbers of
older persons living with chronic illnesses.
MYTH 4
Aggressive hospital care for the aged is futile; the
money spent is wasted.
Fact: Many older people who receive aggressive
care survive and do well for an extended period.
One of the most common myths surrounding
health care in old age is that aggressive treatment
is too often “wasted” on patients who, because of
age, cannot benefit from it. The facts are that
many older people do benefit from aggressive care,
and age alone is not the major determinant of who
will benefit.
Several measures have been used to study the
impact of aggressive care on the outlook for older
5
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persons. These include the high cost itself, admis-
sion to intensive care, the length of stay in inten-
sive care, the number of people receiving certain
high-cost procedures, as well as the cost of receiv-
ing care in teaching hospitals.
The benefits of aggressive care for older persons
are demonstrated by Medicare data showing that
among beneficiaries who incur high costs, there
are about as many who survive as who die in the
course of a calendar year. For instance, among
those who cost Medicare more than $20,000 in
1978, 24,000 died and 25,000 survived in that
year.1 In four other years, the percent of Medicare
enrollees who incurred the highest costs were
divided about equally between those who survived
and those who died in the course of the year.2
These data suggest, retrospectively, that high-cost
(or aggressive) care has benefits for people age 
65 and over about half the time, if one accepts 
survival as an indication of benefit.
Since then, many studies have attempted to address
the question of whether age should determine the
aggressiveness and intensity of inpatient care 
provided to older adults. Although some studies have
suggested that older adults in intensive care have
higher mortality rates,3,4 many other studies have
concluded that age itself is not the most significant
predictor of outcome in the intensive care unit.5-8
One study suggests that although older patients
admitted to intensive care tend to have a decrease
in general level of activity including specific activi-
ties of daily living from baseline one year after
their ICU stay, the cumulative mortality at 12
months was only 25 percent. More importantly,
the self-perceived health status of the very old 
(75 and over) increased over the course of the year,
and about 70 percent of all patients discharged
were living at home at 12 months.9
Another study involving older adults (70 years and
over) with a longer than 30-day stay in the ICU
showed similar results. Despite a sicker group of
older adults requiring a longer ICU stay, the sur-
vival rate was 67 percent in the ICU and 47 per-
cent in the hospital, comparable to the Medicare
estimates described earlier. Once again, although
independence in activities of daily living (except
for feeding) was significantly decreased after the
ICU stay, their perceived quality of life remained
good, and most remained independent with the
possibility of returning home.10
These studies, along with the Medicare data, sup-
port the fact that aggressive care has benefited
older adults about half the time by extending their
lives. But is survival the endpoint of any medical
care? Many would argue that with the increasing
medical costs that face our nation today, the bene-
fit of aggressive ICU care cannot be measured by
life extension itself. Other clinically valuable end-
points such as perceived quality of life and func-
tional status need to be considered.
A review of the literature on outcomes of aged
survivors of intensive care gathered from 1990 to
2003 looked specifically at this question. What the
researchers found was that in most studies, criti-
cally ill older patients have good functional status
and/or health-related quality of life, they were sat-
isfied with their life, and there was little change
from their premorbid health-related quality of life
following discharge from the ICU.11
It is clear from all these various sources that many
older adults would benefit from aggressive treat-
ment. If it were possible, prospectively, to identify
patients who would benefit and patients who
would not, physicians and patients together could
choose care accordingly. At present, physicians do
not have a reliable way to predict the outcome of
    
treatment in older patients or, with the exception
of terminal cancer, to predict with much accuracy
how long a patient has to live. Even the use of
complex scoring formulas that take many factors
into account fail to yield precise predictions of life
expectancy in critically ill patients. The APACHE
model (Acute Physiology, Age, Chronic Health
Evaluation) has improved the accuracy of predic-
tions in groups of patients but has not proved use-
ful in predicting which individual patients will
die.12 The SUPPORT (Study to Understand
Prognoses and Preference for Outcomes and Risks
of Treatment) prognostic model found that seven
days before death, patients had a median 51 per-
cent likelihood of surviving two months. Even one
day before death, the median likelihood of surviv-
ing two months was 17 percent.13 What this
demonstrates is that although available clinical
information can provide some long-term survival
estimates, the best estimate is probably that which
combines the objective prognosis from these mod-
els with a physician’s clinical estimate.14
One clear fact that does emerge from studies of
prognostic models is that age alone is not a good
predictor of whether treatment will be successful.
Both the APACHE III and the SUPPORT model
include age as one prognostic element, along with
physiologic and other variables. In neither case,
however, does age appear to play a major role com-
pared to other variables.14,15 A study looking at the
long-term outcome of critically ill older patients
requiring intensive care further supports this by
showing that age alone was neither an adequate
predictor of long-term survival, nor was it an 
adequate predictor of patients’ quality of life 
12 months after hospital discharge.6
In summary, the common assumption that “intensive
care for the elderly is futile” is not borne out by the
evidence. Age alone is not a good basis for making
prognoses, nor should it be the only determinant
used to restrict aggressive medical care. Because the
outcome of any aggressive treatment is hard to pre-
dict, any decisions to limit aggressive treatment of
older adults should take into consideration not only
age, functional status, and health-related quality of
life but also other factors, including societal values.
One of the pressing needs in end-of-life care is the
development of better models to enable physicians to
give patients and their families reliable prognoses,
and particularly, to let them know when further
treatment will indeed be futile.
MYTH 5
It is common for older people to receive heroic,
high-tech treatments at the end of life.
Fact: Only a fraction of people over age 65 receive
aggressive care at the end of life. The older people
are, the less likely they are to receive aggressive
care when dying. 
A terminally ill 90-year-old lives out his last weeks
connected to tubes and a ventilator, his dying pro-
longed by a health care system infatuated with
technology and insensitive to human suffering:
This is a familiar image, one that haunts many
people on a personal level and appears often in
media coverage of death and dying.
It is easy to assume from this image that a high-
tech, senselessly prolonged dying process is com-
mon in old age and that it is a major reason for
rising Medicare costs. But are such deaths com-
mon? In fact, there are various ways to measure the
aggressiveness of care for older persons, and all
cast doubt on this assumption.
One measure of the aggressiveness of care is cost.
Data from the Health Care Financing Adminis-
tration show that about 6 to 8 percent of Medicare
7
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enrollees die each year, and they account for about
27 to 30 percent of annual Medicare expenditures.1,2
About half of Medicare costs in the last year of life
are incurred in the last 60 days and about 40 per-
cent in the last 30 days.2 These figures have
strengthened the belief that older persons fre-
quently receive intensive futile hospital care.
But a closer look at the Medicare data shows oth-
erwise. While hospital care at the end of life does
account for a large portion of Medicare costs,
spending for aggressive care is not a major compo-
nent of these costs. In fact, only about 3 percent of
Medicare beneficiaries who die incur very high
costs of the kind that suggest aggressive care.1,2
In 1990, the Congressional Research Service
reviewed existing studies and concluded that
“analysis of expenditure patterns lends little sup-
port to the assertion that high technology medical
care for the terminally ill contributes dispropor-
tionately to expenditures for those who die or to
the argument that overall spending at the end of
life is inordinately high and could be reduced.”3
The conclusion reached by analysts of the late
1980s and early 1990s that “the high cost of
dying” is not the major reason why health care
spending is increasing still appears to be true.2,4
This is evidenced by the fact that the portion of
Medicare expenditure for patients in the last year
of life has been stable for the last two decades.5
NONTEACHING HOSPITALS TEACHING HOSPITALS
Estimated Total Costs and Length of Stay According to Age Group in Nonteaching vs. Teaching Hospitals
Figure 6
Age Group Mean Total Mean Length Mean Total Mean Length Difference in  Mean Total Cost
(Years) Costs ($) of Stay (Days) Costs ($) of Stay (Days) Between Hospitals (Percent)
60–69 6,030 7.0 10,524 7.8 42.7
70–79 6,406 8.3 11,542 9.2 44.5
80–89 6,177 9.4 9,499 9.5 35.0
90–99 5,616 9.5 7,338 9.0 23.5
>100 5,330 9.8 6,198 8.3 14.0
DECEDENTS SURVIVORS
Average Estimated Total and Ancillary Costs per Discharge to Age Group and Survivor Status at Discharge* 
Figure 7
Age Group Number of Total Costs Ancillary Costs Number of Total Costs Ancillary Costs
(Years) Patients ($) ($) Patients ($) ($)
60–69 7,387 16,886 9,463 201,939 6,981 3,705
70–79 13,467 14,917 8,059 241,820 7,163 3,470
80–89 12,887 10,557 4,654 157,481 6,492 2,622
90–99 4,050 6,977 2,737 34,866 5,784 2,044
>100 145 6,523 1,660 857 5,313 2,499
* P < .000I for differences between decedents and survivors; for both total and ancillary costs, except for the age group of 100 or more years.
Source: Perls TT, Wood ER. 1996. Acute care costs of the oldest old. Arch Intern Med 156:759.
                 
Aggressiveness of Care vs. Age
Some of the data on this issue come from a long-
term study of treatments and decision making for
seriously ill hospitalized patients called SUPPORT
(Study to Understand Prognoses and Preferences
for Outcomes and Risks of Treatment). The largest
study ever to look at the care of critically ill and
dying patients, SUPPORT collected data over a
period of five years on 9,105 adults hospitalized
with one or more of nine life-threatening diag-
noses in five medical centers across the country.
This study found that compared to patients who
are younger than age 50, patients over 80 years of
age are less likely to undergo three procedures rep-
resenting aggressive care—major surgery, dialysis,
and right heart catheter placement.6 This finding
persisted even after adjusting for patient prefer-
ences for life-extending care. By a second measure—
the overall intensity of care—older SUPPORT
patients received fewer invasive procedures and
fewer aggressive, resource-intensive, and costly care.
In fact, older patients may receive less aggressive
care even when severity of illness and prior 
functional status are comparable to those of
younger patients. One SUPPORT analysis found
that “do not resuscitate” orders were written ear-
lier (in the course of the study) for patients age 75
and older regardless of prognosis.7 These findings
suggest, as the researchers note, that “physicians
may be using age in a way that is inconsistent
with the reported association between age and
survival.”
Other researchers have looked at the question of
age and aggressiveness of care from different per-
spectives and come up with similar conclusions.
A preliminary study analyzing 0.1 percent of all
Medicare claims for the years 1993 to 1998
showed that Medicare spending in the last year 
of life is strongly associated with age. Medicare
expenditures were 70 percent higher for those
who were 65 to 69 compared to those who were
85 or over.8 In fact, the reported expenditures for
younger decedents (65 to 69) was twice that of
the oldest decedents (85 or over) for inpatient care
and two and a half times for outpatient services.
A different study examined the cause of this phe-
nomenon and found that the decrease in expendi-
ture for those 85 or over is due to the fact that the
aggressiveness of medical care in the last year of
life decreases with increasing age, as judged by less
frequent hospital and intensive care unit admis-
sions and by the markedly decreased use of car-
diac catheterization, dialysis, ventilators, and
pulmonary artery monitors, regardless of the 
cause of death.9
A study of Massachusetts hospital patients found
that those age 90 and over tended to have condi-
tions that involved less acute care than people in
their sixties.10 Regardless of diagnosis, the oldest
people in this study had lower rates of aggressive
care than people ages 60 to 69. For example, they
had lower ancillary charges (charges other than
those for the hospital room, such as use of the
operating room and radiology services). In addi-
tion, people age 80 and over in this study were
less likely to be admitted to teaching hospitals and
more likely to enter lower-cost community hospi-
tals (Figures 6 and 7). Again it appears, as the
SUPPORT researchers noted, that some informal
age-based rationing of hospital care is in effect.
Functional Status vs. Age
Who receives aggressive, high-technology care at
the end of life? A study of 261 patients in a group
practice in Palo Alto, California, showed that
high-tech care more often went to people with
9
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good functional status (ability to carry out basic
activities such as dressing and bathing) 12 months
prior to death. In other words, quite reasonably,
aggressive care was going to “the kind of patients a
physician would not feel justified in not treating
aggressively.”11
Although total expenses did not differ substan-
tially for the different functional groups in this
study—the unimpaired, partially impaired, or
totally impaired—costs by type or service did dif-
fer strikingly. Regardless of age, average hospital
expenses were much higher for the unimpaired
($18,000) than for the totally impaired ($3,000)
and the partially impaired ($11,600). Physician
costs for the totally impaired were about a third of
those for the unimpaired. On the other hand,
nursing home and home health care costs were
sharply higher for the totally impaired than the
unimpaired, offsetting their lower hospital and
physician costs.11
Finally, there is no evidence that aggressive care at
the end of life is increasing, nor is there evidence
that the cost of dying is growing and will over-
whelm the health care system. What researchers
did find suggests that physicians and hospitals are
not blindly ordering heroic measures to prolong
dying. Perhaps much of what was thought to be the
“high cost of dying” was just the cost of providing
regular care to those with severe illness and func-
tional impairments.5 Providing care to the very sick
is expensive. The more crucial issues for policymak-
ers center on supportive care for the aged who are
close to death. How should clinical decisions be
made regarding when such care is appropriate, and
how and when they should be provided? The
increasing availability of palliative care programs in
hospitals may provide valuable services to clinicians
caring for seriously ill persons.
MYTH 6
Medicare covers everything that older adults need
in terms of their health care.
Fact: Medicare does not cover several essential
components of health care for older Americans.
As a result of technological innovation as well as
the advent of myriad treatments for medical ill-
ness, life expectancy has grown sharply over the
past 50 years. The percentage of older persons
within the United States is likely to continue to
rise. In fact, it is estimated that the portion of
older persons within our population will increase
from one in eight in 1994 to one in five by 2030.1
As our collective population ages, more and more
U.S. citizens depend on Medicare as their primary
health insurance plan. The vast majority of them,
however, incorrectly assume that Medicare will
provide absolute financial support for their health
care. In truth, Medicare covers only a fraction of
the care that they will likely need.
Whereas far below 1 percent of our nonaged pop-
ulation suffers from dementia, approximately 6 to
10 percent of older Americans have dementia.2
Thus, one unfortunate consequence of the increase
in life expectancy within the United States is that
the proportion of our population with dementia is
on the rise. Progression of dementia usually goes
hand in hand with dependency on others for cus-
todial care. Those without family members willing
to provide the needed level of care are compelled
to seek out assistance from home health aides and
nursing homes. Such assistance can be very expen-
sive; in 2006, the average annual cost of nursing
home care within the United States was more than
$75,000.3 The amount spent on home health care
in 2002 was over $26 billion. Seven out of ten
patients who receive this care are ages 65 and
         
older. Nonetheless, Medicare pays for custodial
services only in the setting of acute illness; it does
not pay for long-term care.
With a growing population of older adults who are
living longer with chronic illnesses, our nation will
be faced with increasing numbers of older persons
who become frail and homebound. When these
individuals have an acute decompensation, they can
receive home nursing care services. When they are
dying (have a less than six-month prognosis), they
are entitled to hospice care services. But if they are
neither dying nor acutely ill, the frail aged may find
themselves falling through the cracks of our health
care system. They may not be able to obtain med-
ical care because there are not enough doctors who
make home visits. They may not qualify for skilled
nursing services under Medicare regulations. This
is a serious gap that will require attention. It would
be useful to allow patients who are expected to live
for 12 months to become eligible for hospice care,
and to offer palliative care for the frail and home-
bound who are not dying.
In addition, the aged are the cohort within our
population at highest risk for falling, as well as for
sustaining injury from any one given fall. As a
whole they have multiple risk factors for falling,
including cognitive decline, poor vision, poor hear-
ing, and gait impairment. In fact, balance among
the aged population is so poor that 75 to 90 per-
cent of disabled older community-dwelling adults
require assistive technology such as canes, walkers,
or wheelchairs.4 And although Medicare was
designed for older Americans, it does not provide
for hearing aids, general hearing care, eyeglasses,
or eye exams (except for postcataract surgery 5).
Furthermore, Medicare has stringent criteria for
coverage of wheelchairs, walkers, or canes under its
Durable Medical Equipment (DME) benefits. As
a result, more than half of the population of older
adults who require assistive technology for mobil-
ity pay for it out of pocket.4 And mobility equip-
ment can be expensive; whereas the average cost of
a cane was $52 in 2001, the average power wheel-
chair cost more than $6,000.4 Nor does Medicare
cover routine dental care.
It is incumbent upon Medicare to educate the public
about the services it covers as well as those it does
not. Insurance coverage for long-term care is too
expensive for most people once they reach the status
of “older American.” As of now, approximately 16
percent of nursing home residents have been bank-
rupted by the cost of their care. Whereas at one
point they were paying for their care out of pocket,
they now rely on Medicaid for nursing home cover-
age.6 It is imperative that we find a way to allow
nursing home–dependent, aged individuals to obtain
the care they need without compromising all of their
life savings. This will not happen unless the general
public is apprised of Medicare’s shortcomings.
MYTH 7
If all older patients had living wills or other kinds of
advance directives, it would resolve dilemmas of
how aggressively to provide care.
Fact: Living wills and other forms of advance
directives frequently have little impact on or rele-
vance to end-of-life decision making. And physi-
cians and other health care professionals often
lack training to help them to empathically and
effectively communicate with patients and family
members about the options, potential outcomes,
and time-limited trials.  
Case: R.F. is a 90-year-old retired business manager
who has an aged wife and no children. He has moder-
ate dementia, physical deconditioning, unsteady gait,
and a progressing frailty syndrome. He fell at home
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and was hospitalized for hip fracture repair. He was
then sent to subacute rehabilitation but made little
progress. He returned to the hospital for urosepsis,
acquired hospital-related infections, developed respira-
tory failure, and was placed on a breathing machine
(life support). His kidneys also began to fail, and he
received a feeding tube for artificial nutrition. His
wife and nephew were told by the physician that there
was no hope of his recovery, and R.F. was referred to
hospice. During a family meeting, Mrs. F. told the
team that R.F. had told her he “never wanted to be
sustained by machines.” R.F. even clearly stated these
wishes in his living will and health care proxy form.
However, Mrs. F. felt powerless to honor these wishes
because she felt she would be “pulling the plug” on R.F.
With counseling and support from the hospice doctor
and her nephew, Mrs. F. decided to stop the breathing
machine the next day. The hospital intern and attend-
ing did not wish to stop the artificial feeding until the
patient was “officially” a hospice patient, even though
the patient had clear and convincing wishes and was
fluid overloaded and extremely swollen. R.F. died the
next day, with all the machines that he did not want.
Faced with medicine’s increasing ability to save
and prolong lives with high-technology care, many
people have turned to advance directives to guide
decisions about use of such care in the event they
are unable to make these decisions themselves. The
Patient Self-Determination Act (PSDA) in 1990
mandated that health care institutions inquire
about and document existing advance directives at
the time of hospital or nursing home admission.
Have advance directives fulfilled their promise?
Not so far, say researchers who have identified sev-
eral barriers and challenges to their use. To say the
least, advance directives discussions are complex,
entailing multiple variables.
One of the barriers appears to be that advance
directives are still not well integrated into our
health care system despite the passage of the
PSDA. The prevalence of advance directives among
the U.S. population varies between 5 percent and
35 percent. This statistic is well documented in
SUPPORT (Study to Understand Prognoses and
Preferences for Outcomes and Risks of Treatment),
a study that took place between 1989 and 1994
(encompassing the years before and after the pas-
sage and implementation of PSDA) and enrolled
9,105 patients who were seriously ill. In a subset 
of 2,162 seriously ill patients, less than a quarter 
(23 percent) had discussed preferences regarding
cardiopulmonary resuscitation with their physi-
cians; of those who had not had discussions,
58 percent were not interested in doing so.1 In a
study by Goodman et al. of 401 older patients
admitted to the intensive care unit between 1992
and 1995, only 5 percent had advance directives.2
Another study of critically ill cancer patients found
that advance directives were completed in only 
27 percent of cases.3 Furthermore, there are consid-
erable variations in the acceptability and execution
of advance directives among various ethnic groups,
with higher acceptance rates among Caucasians as
compared to African Americans, Hispanic
Americans, and Asian Americans.4
A second barrier occurs even when advance direc-
tives are in place. These directives may not neces-
sarily impact care or reduce resource utilization.
According to Teno et al. in the SUPPORT study,
chart documentation of existing advance directives
increased with both the PSDA and the SUPPORT
intervention.5 However, there was no corresponding
change in hospital resource use. As a matter of fact,
SUPPORT intervention patients with early docu-
mentation of advance directives showed a trend
toward greater cost compared with those patients
who had no advance directives documentation. In
the Goodman study, the level of care delivered to
older ICU patients was not affected by the pres-
ence or absence of advance directives statements.
    
For example, CPR was administered to 11 percent
of the patients who died with advance directives
that specifically stated they did not want CPR.
Thirdly, advance directives should be more compre-
hensive than just the discussion of resuscitation.
They need to elicit thinking about what kind of life
is worth living and what is not; what are the physi-
cal and mental conditions that would impede a
meaningful existence; what are the patient’s per-
sonal experiences and what are the risks and bene-
fits of various interventions. Tools, such as the
POLST,6 the MOLST,7 Five Wishes,8 and the
Halachic Living Will, are including these higher
levels of discussions.9
A fourth challenge is improving the system by
which hospitalized patients receive and complete
advance directives. Currently, a patient is admitted
to a hospital or nursing home and receives a pack-
age of materials, including advance directives.
Finally, because advance directives state care pref-
erences in the setting of serious illness, all physi-
cians and health care professionals must be trained
in communication skills. If physicians and 
practitioners cannot guide patients and surrogates
in a compassionate and competent manner, offer
options and alternatives, and support patients/
families through difficult decision making, then all
is for naught. Traditionally, medical professionals
have not been properly educated about communi-
cations that involve goals of care. Adding to 
this mix is the uncertainty of prognosis in most 
illnesses, making these conversations all the more
challenging.
The issue, in other words, is complex. Simply get-
ting more patients to write advance directives, even
getting more hospitals to incorporate them into
patient records, may have little impact in the face
of the aforementioned challenges and barriers.
With the emergence of palliative care consult serv-
ices in hospitals and long-term care facilities, more
meaningful conversations about advance directives
that can impact care may take place. Some key
focus areas for research and debate are how and
whether the improved advance planning tools can
make a difference in a patient’s clinical experience
and whether palliative care consults can impact
patients’ care.
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